Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Nguyen, TN; Qureshi, MM; Klein, P; Yamagami, H; Abdalkader, M; Mikulik, R; Sathya, A; Mansour, OY; Czlonkowska, A; Lo, H; Field, TS; Charidimou, A; Banerjee, S; Yaghi, S; Siegler, JE; Sedova, P; Kwan, J; de, Sousa, DA; Demeestere, J; Inoa, V; Omran, SS; Zhang, L; Michel, P; Strambo, D; Marto, JP; Nogueira, RG; Kristoffersen, ES; Tsivgoulis, G; Lereis, VP; Ma, A; Enzinger, C; Gattringer, T; Rahman, A; Bonnet, T; Ligot, N; De, Raedt, S; Lemmens, R; Vanacker, P; Vandervorst, F; Conforto, AB; Hidalgo, RCT; Mora, Cuervo, DL; de, Oliveira, Neves, L; Lameirinhas, da, Silva, I; Martíns, RT; Rebello, LC; Santiago, IB; Sakelarova, T; Kalpachki, R; Alexiev, F; Cora, EA; Kelly, ME; Peeling, L; Pikula, A; Chen, HS; Chen, Y; Yang, S; Roje, Bedekovic, M; Čabal, M; Tenora, D; Fibrich, P; Dušek, P; Hlaváčová, H; Hrabanovska, E; Jurák, L; Kadlčíková, J; Karpowicz, I; Klečka, L; Kovář, M; Neumann, J; Paloušková, H; Reiser, M; Rohan, V; Šimůnek, L; Skoda, O; Škorňa, M; Šrámek, M; Drenck, N; Sobh, K; Lesaine, E; Sabben, C; Reiner, P; Rouanet, F; Strbian, D; Boskamp, S; Mbroh, J; Nagel, S; Rosenkranz, M; Poli, S; Thomalla, G; Karapanayiotides, T; Koutroulou, I; Kargiotis, O; Palaiodimou, L; Barrientos, Guerra, JD; Huded, V; Nagendra, S; Prajapati, C; Sylaja, PN; Sani, AF; Ghoreishi, A; Farhoudi, M; Sadeghi, Hokmabadi, E; Hashemilar, M; Sabetay, SI; Rahal, F; Acampa, M; Adami, A; Longoni, M; Ornello, R; Renieri, L; Romoli, M; Sacco, S; Salmaggi, A; Sangalli, D; Zini, A; Sakai, K; Fukuda, H; Fujita, K; Imamura, H; Kosuke, M; Sakaguchi, M; Sonoda, K; Matsumaru, Y; Ohara, N; Shindo, S; Takenobu, Y; Yoshimoto, T; Toyoda, K; Uwatoko, T; Sakai, N; Yamamoto, N; Yamamoto, R; Yazawa, Y; Sugiura, Y; Baek, JH; Lee, SB; Seo, KD; Sohn, SI; Lee, JS; Arsovska, AA; Chieh, CY; Wan, Zaidi, WA; Wan, Yahya, WNN; Gongora-Rivera, F; Martinez-Marino, M; Infante-Valenzuela, A; Dippel, D; van, Dam-Nolen, DHK; Wu, TY; Punter, M; Adebayo, TT; Bello, AH; Sunmonu, TA; Wahab, KW; Sundseth, A; Al, Hashmi, AM; Ahmad, S; Rashid, U; Rodriguez-Kadota, L; Vences, MÁ; Yalung, PM; Dy, JSH; Brola, W; Dębiec, A; Dorobek, M; Karlinski, MA; Labuz-Roszak, BM; Lasek-Bal, A; Sienkiewicz-Jarosz, H; Staszewski, J; Sobolewski, P; Wiącek, M; Zielinska-Turek, J; Araújo, AP; Rocha, M; Castro, P; Ferreira, P; Nunes, AP; Fonseca, L; Pinho, E, Melo, T; Rodrigues, M; Silva, ML; Ciopleias, B; Dimitriade, A; Falup-Pecurariu, C; Hamid, MA; Venketasubramanian, N; Krastev, G; Haring, J; Ayo-Martin, O; Hernandez-Fernandez, F; Blasco, J; Rodríguez-Vázquez, A; Cruz-Culebras, A; Moniche, F; Montaner, J; Perez-Sanchez, S; García, Sánchez, MJ; Guillán, Rodríguez, M; Bernava, G; Bolognese, M; Carrera, E; Churojana, A; Aykac, O; Özdemir, AÖ; Bajrami, A; Senadim, S; Hussain, SI; John, S; Krishnan, K; Lenthall, R; Asif, KS; Below, K; Biller, J; Chen, M; Chebl, A; Colasurdo, M; Czap, A; de, Havenon, AH; Dharmadhikari, S; Eskey, CJ; Farooqui, M; Feske, SK; Goyal, N; Grimmett, KB; Guzik, AK; Haussen, DC; Hovingh, M; Jillela, D; Kan, PT; Khatri, R; Khoury, NN; Kiley, NL; Kolikonda, MK; Lara, S; Li, G; Linfante, I; Loochtan, AI; Lopez, CD; Lycan, S; Male, SS; Nahab, F; Maali, L; Masoud, HE; Min, J; Orgeta-Gutierrez, S; Mohamed, GA; Mohammaden, M; Nalleballe, K; Radaideh, Y; Ramakrishnan, P; Rayo-Taranto, B; Rojas-Soto, DM; Ruland, S; Simpkins, AN; Sheth, SA; Starosciak, AK; Tarlov, NE; Taylor, RA; Voetsch, B; Zhang, L; Duong, HQ; Dao, VP; Le, HV; Pham, TN; Ton, MD; Tran, AD; Zaidat, OO; Machi, P; Dirren, E; Rodríguez, Fernández, C; ....
Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality.
J Stroke. 2022; 24(2): 256-265.
Doi: 10.5853/jos.2022.00752
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Enzinger Christian
- Gattringer Thomas
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- BACKGROUND AND PURPOSE: Recent studies suggested an increased incidence of cerebral venous thrombosis (CVT) during the coronavirus disease 2019 (COVID-19) pandemic. We evaluated the volume of CVT hospitalization and in-hospital mortality during the 1st year of the COVID-19 pandemic compared to the preceding year. METHODS: We conducted a cross-sectional retrospective study of 171 stroke centers from 49 countries. We recorded COVID-19 admission volumes, CVT hospitalization, and CVT in-hospital mortality from January 1, 2019, to May 31, 2021. CVT diagnoses were identified by International Classification of Disease-10 (ICD-10) codes or stroke databases. We additionally sought to compare the same metrics in the first 5 months of 2021 compared to the corresponding months in 2019 and 2020 (ClinicalTrials.gov Identifier: NCT04934020). RESULTS: There were 2,313 CVT admissions across the 1-year pre-pandemic (2019) and pandemic year (2020); no differences in CVT volume or CVT mortality were observed. During the first 5 months of 2021, there was an increase in CVT volumes compared to 2019 (27.5%; 95% confidence interval [CI], 24.2 to 32.0; P<0.0001) and 2020 (41.4%; 95% CI, 37.0 to 46.0; P<0.0001). A COVID-19 diagnosis was present in 7.6% (132/1,738) of CVT hospitalizations. CVT was present in 0.04% (103/292,080) of COVID-19 hospitalizations. During the first pandemic year, CVT mortality was higher in patients who were COVID positive compared to COVID negative patients (8/53 [15.0%] vs. 41/910 [4.5%], P=0.004). There was an increase in CVT mortality during the first 5 months of pandemic years 2020 and 2021 compared to the first 5 months of the pre-pandemic year 2019 (2019 vs. 2020: 2.26% vs. 4.74%, P=0.05; 2019 vs. 2021: 2.26% vs. 4.99%, P=0.03). In the first 5 months of 2021, there were 26 cases of vaccine-induced immune thrombotic thrombocytopenia (VITT), resulting in six deaths. CONCLUSIONS: During the 1st year of the COVID-19 pandemic, CVT hospitalization volume and CVT in-hospital mortality did not change compared to the prior year. COVID-19 diagnosis was associated with higher CVT in-hospital mortality. During the first 5 months of 2021, there was an increase in CVT hospitalization volume and increase in CVT-related mortality, partially attributable to VITT.
- Find related publications in this database (Keywords)
- COVID-19
- Cerebral venous thrombosis
- Vaccine-induced immune thrombotic thrombocytopenia
- Mortality
- SARS-CoV-2
- Stroke